Zheng Minwen, Wu Yongjie, Wei Mengqi, Liu Ying, Zhao Hongliang, Li Jian
Department of Radiology, Xijing Hospital, Fourth Military Medical University, No. 169, West Changle Road, Xi'an, Shaanxi Province 710032, China.
Department of Radiology, Xijing Hospital, Fourth Military Medical University, No. 169, West Changle Road, Xi'an, Shaanxi Province 710032, China.
Acad Radiol. 2015 Feb;22(2):195-202. doi: 10.1016/j.acra.2014.07.025. Epub 2014 Nov 11.
To assess the impact of low-concentration contrast medium on vascular enhancement, image quality, and radiation dose of coronary computed tomography (CT) angiography (CCTA) by using prospectively electrocardiography (ECG)-triggered high-pitch spiral acquisition with low tube voltage in combination with iterative reconstruction.
One hundred patients (body mass index ≤ 25 kg/m(2), heart rate ≤ 65 beats per minute) were prospectively randomized to two groups, with 50 patients each, which were differed by contrast medium. All patients underwent prospectively ECG-triggered high-pitch spiral acquisition CCTA (2 × 128 × 0.6 mm, 300 mAs). Group A patients received iopromide 370 (370 mg I/mL), were scanned using 100 kVp, and reconstructed with filtered back projection. Group B patients received Iodixanol 270 (270 mg I/mL), were scanned using low tube voltage of 80 kVp, and reconstructed with iterative reconstruction techniques (IRT). CT attenuation was measured in coronary artery and other anatomic regions. Image quality score, noise, signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and radiation dose were calculated and compared.
The iodixanol 270 group showed no significant difference in image quality score (1.61 ± 0.69 vs 1.57 ± 0.66; P > .05), CT attenuation (P > .05), noise (P > .05), SNR (47.89 ± 14.03 vs 44.37 ± 12.79; P > .05), and CNR (42.38 ± 12.67 vs 38.13 ± 11.38; P > .05) in comparison to the iopromide 370 group but at a significantly lower radiation dose (0.26 ± 0.05 vs 0.57 ± 0.10; P < .001), which reflects dose saving of 54.4%.
Combining IRT with high-pitch spiral acquisition mode and low-tube-voltage technique, a low-concentration contrast medium of 270 mg I/mL can still maintain the contrast enhancement in coronary arteries without impairing image quality and significantly lower the radiation dose.
通过前瞻性心电图(ECG)触发的高螺距螺旋采集、低管电压结合迭代重建技术,评估低浓度对比剂对冠状动脉计算机断层扫描(CT)血管造影(CCTA)的血管强化、图像质量及辐射剂量的影响。
100例患者(体重指数≤25kg/m²,心率≤65次/分钟)被前瞻性随机分为两组,每组50例,两组对比剂不同。所有患者均接受前瞻性ECG触发的高螺距螺旋采集CCTA(2×128×0.6mm,300mAs)。A组患者使用碘普罗胺370(370mg I/mL),采用100kVp扫描,滤波反投影重建。B组患者使用碘克沙醇270(270mg I/mL),采用80kVp的低管电压扫描,迭代重建技术(IRT)重建。测量冠状动脉及其他解剖区域的CT衰减。计算并比较图像质量评分、噪声、信噪比(SNR)、对比噪声比(CNR)及辐射剂量。
与碘普罗胺370组相比,碘克沙醇270组在图像质量评分(1.61±0.69 vs 1.57±0.66;P>.05)、CT衰减(P>.05)、噪声(P>.05)、SNR(47.89±14.03 vs 44.37±12.79;P>.05)及CNR(42.38±12.67 vs 38.13±11.38;P>.05)方面无显著差异,但辐射剂量显著降低(0.26±0.05 vs 0.57±0.10;P<.001),辐射剂量节省了54.4%。
将IRT与高螺距螺旋采集模式及低管电压技术相结合,270mg I/mL的低浓度对比剂仍可维持冠状动脉的对比增强,不影响图像质量,并显著降低辐射剂量。